×

Our award-winning reporting has moved

Context provides news and analysis on three of the world’s most critical issues:

climate change, the impact of technology on society, and inclusive economies.

Plane carrying British Ebola victim leaves Sierra Leone for Britain

by Reuters
Sunday, 24 August 2014 13:45 GMT

DATE IMPORTED: August 24, 2014 File photograph shows senior Matron Breda Athan demonstrates putting on the protective suit which would be used if it becomes necessary to treat patients suffering from Ebola, at The Royal Free Hospital in London August 12, 2014. REUTERS/Suzanne Plunkett/Files

Image Caption and Rights Information

FREETOWN, Aug 24 (Reuters) - A Royal Air Force plane carrying a British healthcare worker who contracted Ebola in Sierra Leone - the first Briton to catch the deadly virus - took off from the capital Freetown on Sunday bound for Britain.

The British man, whose name has not been released, was brought by ambulance to the Boeing C-17 cargo plane. The flight took off at around 1250 GMT.

The U.K. Department of Health said in a statement the man was not seriously ill and it had decided to repatriate the British national following clinical advice.

Upon arrival at the RAF Northolt airbase in Britain, he will be transported to an isolation unit at the Royal Free Hospital in London, the department said.

"Protective measures will be strictly maintained to minimise the risk of transmission to staff transporting the patient to the UK and healthcare workers treating the individual," said Paul Cosford, Director for Health Protection at Public Health England.

The outbreak of the hemorrhagic fever in West Africa - the worst since the disease was discovered in the jungles of Central Africa in 1976 - has so far killed at least 1,427 people, mostly in Sierra Leone, Liberia and neighbouring Guinea. Five deaths have also been reported in Nigeria.

Two American doctors who contracted Ebola in Liberia and were evacuated to the United States left hospital last week after receiving treatment with an experimental drug, ZMapp.

The U.S.-based manufacturer, Mapp Biopharmaceutical, has said limited supplies of the drug have already been exhausted.

(Reporting by Josephus Olu-Mammah in Freetown and Kylie MacLellan in London; Writing by Daniel Flynn)

Our Standards: The Thomson Reuters Trust Principles.

-->